Description Module
The Description Module contains narrative descriptions of the clinical trial, including a brief summary and detailed description. These descriptions provide important information about the study's purpose, methodology, and key details in language accessible to both researchers and the general public.
Description Module path is as follows:
Study -> Protocol Section -> Description Module
Description Module
Ignite Creation Date:
2025-12-25 @ 2:08 AM
Ignite Modification Date:
2025-12-25 @ 2:08 AM
NCT ID:
NCT01211860
Brief Summary:
Once a day oral administration with DCCR is the optimal dosing regimen
Detailed Description:
POPULATION The population will consist of generally healthy subjects with elevated fasting triglyceride levels in the range of ≥ 150 mg/dL and ≤ 1500 mg/dL at the Screening Visit.
Number of Subjects A total of 10 subjects will be enrolled in the study at 1 site in the USA.
Study:
NCT01211860
Study Brief:
Protocol Section:
NCT01211860